Impact of Non-pharmacological Intervention Policies on COVID-19 Infection
Journal: Journal of Clinical Medicine Research DOI: 10.32629/jcmr.v5i3.2784
Abstract
The spread of COVID-19 has caused great distress to people in countries around the world. Pending the development of the special-effect drug that can treat COVID-19, every country in the world has adopted various non-pharmaceutical intervention policies (NPI) to stop the spread of the pandemic and reduce its impact on society. This study used logistic regression to model mortality and infection rates in the two countries, exploring which NPI policies had an impact on the decline in mortality and infection rates in the two countries. This study analyzes the impact of nine NPI policies on COVID-19 infection and mortality rates and found that. Restrictions on international travel policies contributed to the reduction of COVID-19 infection and mortality in both countries. The workplace closure policy and the in-country travel restriction policy contributed to the mitigation of the epidemic in the UK, while for the Chinese government, the home quarantine policy reduced COVID-19 mortality and infection rates. Overall, the NPI policy enacted by the Chinese government line was more stringent compared to the UK. Governments should carefully consider enacting stricter international travel restriction policies in the event of future epidemics. In terms of the timing of the policy, a long-term NPI policy would be more effective in controlling epidemics.
Keywords
COVID-19; non-pharmacological intervention policies; face mask; international travel bans
Full Text
PDF - Viewed/Downloaded: 0 TimesReferences
[1]Coronavirus disease (covid-19) (no date) World Health Organization. Available at: https://www.who.int/news-room/fact-sheets/detail/coronavirus-disease-(covid-19) (Accessed: 25 October 2023).
[2]Ritchie, H., Mathieu, E., Rodés-Guirao, L., Appel, C., Giattino, C., & Ortiz-Ospina, E. et al. (2022). Coronavirus Pandemic (COVID-19). Retrieved 29 March 2022, from https://ourworldindata.org/coronavirus
[3]Stokes, J., Turner, A. J., Anselmi, L., Morciano, M., & Hone, T. (2022). The relative effects of non- pharmaceutical interventions on wave one Covid-19 mortality: natural experiment in 130 countries. BMC Public Health, 22(1), 1113–1113. https://doi.org/10.1186/s12889-022-13546-6
[4]Lancet, T. (2020). Sustaining containment of COVID-19 in China. Lancet (London, England), 395(10232), 1230.
[5]Hale, T., Angrist, N., Goldszmidt, R., Kira, B., Petherick, A., Phillips, T., ... & Tatlow, H. (2021). A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker). Nature human behaviour, 5(4), 529-538.
[6]Hsiang, S., Allen, D., Annan-Phan, S., Bell, K., Bolliger, I., Chong, T., ... & Wu, T. (2020). The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature, 584(7820), 262-267.
[7]Alshammari, T. M., Alenzi, K. A., Alnofal, F. A., Fradees, G., & Altebainawi, A. F. (2021). Are countries’ precautionary actions against COVID-19 effective? An assessment study of 175 countries worldwide. Saudi pharmaceutical journal, 29(5), 391-409.
[8]Hui, D. S., Azhar, E. I., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., ... & Petersen, E. (2020). The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. International journal of infectious diseases, 91, 264-266.
[9]Davies, N. G., Kucharski, A. J., Eggo, R. M., Gimma, A., Edmunds, W. J., Jombart, T., ... & Liu, Y. (2020). Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study. The Lancet Public Health, 5(7), e375-e385.
[10]Nast, C. (2022). The UK’s lockdown roadmap and rules, explained. Retrieved 30 March 2022, from https://www.wired.co.uk/article/uk-lockdown
[11]OXFORD (2021). COVID-19 Government Response Tracker. [online] www.bsg.ox.ac.uk. Available at: https://www.bsg.ox.ac.uk/research/research-projects/covid-19-government-response-tracker.
[12]Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., ... & Feng, T. (2020). Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. The Lancet infectious diseases, 20(8), 911-919.
[13]Ding, X., Brazel, D. M., & Mills, M. C. (2021). Factors affecting adherence to non-pharmaceutical interventions for COVID-19 infections in the first year of the pandemic in the UK. BMJ open, 11(10), e054200.
[14]Goldberg, M. H., Gustafson, A., Maibach, E. W., Ballew, M. T., Bergquist, P., Kotcher, J. E., Marlon, J. R., Rosenthal, S. A., & Leiserowitz, A. (2020). Mask-Wearing Increased After a Government Recommendation: A Natural Experiment in the U.S. During the COVID-19 Pandemic. Frontiers in Communication, 5, 44.
[15]Anderson, R. M., Heesterbeek, H., Klinkenberg, D., & Hollingsworth, T. D. (2020). How will country-based mitigation measures influence the course of the COVID-19 epidemic?. The lancet, 395(10228), 931-934.
[2]Ritchie, H., Mathieu, E., Rodés-Guirao, L., Appel, C., Giattino, C., & Ortiz-Ospina, E. et al. (2022). Coronavirus Pandemic (COVID-19). Retrieved 29 March 2022, from https://ourworldindata.org/coronavirus
[3]Stokes, J., Turner, A. J., Anselmi, L., Morciano, M., & Hone, T. (2022). The relative effects of non- pharmaceutical interventions on wave one Covid-19 mortality: natural experiment in 130 countries. BMC Public Health, 22(1), 1113–1113. https://doi.org/10.1186/s12889-022-13546-6
[4]Lancet, T. (2020). Sustaining containment of COVID-19 in China. Lancet (London, England), 395(10232), 1230.
[5]Hale, T., Angrist, N., Goldszmidt, R., Kira, B., Petherick, A., Phillips, T., ... & Tatlow, H. (2021). A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker). Nature human behaviour, 5(4), 529-538.
[6]Hsiang, S., Allen, D., Annan-Phan, S., Bell, K., Bolliger, I., Chong, T., ... & Wu, T. (2020). The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature, 584(7820), 262-267.
[7]Alshammari, T. M., Alenzi, K. A., Alnofal, F. A., Fradees, G., & Altebainawi, A. F. (2021). Are countries’ precautionary actions against COVID-19 effective? An assessment study of 175 countries worldwide. Saudi pharmaceutical journal, 29(5), 391-409.
[8]Hui, D. S., Azhar, E. I., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., ... & Petersen, E. (2020). The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. International journal of infectious diseases, 91, 264-266.
[9]Davies, N. G., Kucharski, A. J., Eggo, R. M., Gimma, A., Edmunds, W. J., Jombart, T., ... & Liu, Y. (2020). Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study. The Lancet Public Health, 5(7), e375-e385.
[10]Nast, C. (2022). The UK’s lockdown roadmap and rules, explained. Retrieved 30 March 2022, from https://www.wired.co.uk/article/uk-lockdown
[11]OXFORD (2021). COVID-19 Government Response Tracker. [online] www.bsg.ox.ac.uk. Available at: https://www.bsg.ox.ac.uk/research/research-projects/covid-19-government-response-tracker.
[12]Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., ... & Feng, T. (2020). Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. The Lancet infectious diseases, 20(8), 911-919.
[13]Ding, X., Brazel, D. M., & Mills, M. C. (2021). Factors affecting adherence to non-pharmaceutical interventions for COVID-19 infections in the first year of the pandemic in the UK. BMJ open, 11(10), e054200.
[14]Goldberg, M. H., Gustafson, A., Maibach, E. W., Ballew, M. T., Bergquist, P., Kotcher, J. E., Marlon, J. R., Rosenthal, S. A., & Leiserowitz, A. (2020). Mask-Wearing Increased After a Government Recommendation: A Natural Experiment in the U.S. During the COVID-19 Pandemic. Frontiers in Communication, 5, 44.
[15]Anderson, R. M., Heesterbeek, H., Klinkenberg, D., & Hollingsworth, T. D. (2020). How will country-based mitigation measures influence the course of the COVID-19 epidemic?. The lancet, 395(10228), 931-934.
Copyright © 2024 Lei Liu, Ziqian Geng, Junwei Hou
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License